NCT00638859View on ClinicalTrials.gov

Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Pneumonia
Interventions
DRUG

Telithromycin (HMR3647)

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY